Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleophilic Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110437128B details a mild Ni(II) method for 3-thioether isoindolinones, offering high yields and cost-effective manufacturing for pharmaceutical supply chains.
Patent CN113511986B enables catalyst-free aryl acetonitrile production. Delivers high purity pharmaceutical intermediates with simplified supply chain and cost efficiency.
Catalyst-free synthesis of aryl acetonitrile derivatives enables high-purity API intermediates with simplified scale-up and reduced supply chain risks.